-SiteMap

>> 全站文章索引 >> 第26页:

Quality of life in head and neck cancer patients:validation of the European Organization for Research and Treatment of Cancer Quality of Life - [Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, Biörklund A, de Leeuw]

Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients- associated and predictive factors - [Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y]

Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life - [Stark D, Kiely M, Smith A, Velikova G, House A, Selby P]

Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys - [Belgium: Koen Demyttenaere, Ronny Bruffaerts; Colombia: Jose Posada-Villa; France: Isabelle Gasquet, Viviane Kovess, Jean Pierre Lepine; Germany: Matthias C. Angermeyer, Sebastian Bernert; Italy: Giovanni de Girolamo, Pierluigi Morosini, Gabriella Polidor]

Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIs - [Robert J. Valuck, Ph.D., Anne M. Libby, Ph.D., Heather D. Orton, M.S., Elaine H. Morrato, Dr.PH., Richard Allen, M.S. and Ross J. Baldessarini, M.D.]

Suicide Risk During Antidepressant Treatment - [Gregory E. Simon, M.D., M.P.H., James Savarino, Ph.D., Belinda Operskalski, M.P.H. and Philip S. Wang, M.D., Dr.P.H.]

Long-term Outcomes of Initial Antidepressant Drug Choice in a Real World Randomized Trial - [Gregory E. Simon, MD, MPH; John Heiligenstein, MD; Dennis Revicki, PhD; Michael VonKorff, ScD; Wayne J. Katon, MD; Evette Ludman, PhD; Louis Grothaus, MA; Edward Wagner, MD, MPH]

Determinants of Antidepressant Treatment Compliance: Implications for Policy - [Ming Tai-Seale Thomas W. Croghan Robert Obenchain]

Course of Antidepressant Treatment, Drug Type, and Prescriber's Specialty - [Kathleen A. Fairman, M.A., Wayne C. Drevets, M.D., Jerold J. Kreisman, M.D. and Fred Teitelbaum, Ph.D.]

Treatment Process and Outcomes for Managed Care Patients Receiving New Antidepressant Prescriptions From Psychiatrists and Primary Care Physicians - [Gregory E. Simon, MD, MPH; Michael Von Korff, ScD; Carolyn M. Rutter, PhD; Do A. Peterson, MS]

Continuity of Antidepressant Treatment for Adults With Depression in the United States - [Mark Olfson, M.D., M.P.H., Steven C. Marcus, Ph.D., Michael Tedeschi, R.Ph., M.B.A. and George J. Wan, Ph.D., M.P.H.]

Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure - [SS Derderian, RH Bridenbaugh and KR Rajagopal]

Impact of Antidepressant Discontinuation After Acute Bipolar Depression Remission on Rates of Depressive Relapse at 1-Year Follow-Up - [Lori Altshuler, M.D., Trisha Suppes, M.D., Ph.D., David Black, M.A., Willem A. Nolen, M.D., Ph.D., Paul E. Keck, Jr., M.D., Mark A. Frye, M.D., Susan McElroy, M.D., Ralph Kupka, M.D., Heinz Grunze, M.D., J?rg Walden, M.D., Ph.D., Gabrielle Leverich, M.S.W]

Fatigue in Obstructive Sleep Apnea: Driven by Depressive Symptoms Instead of Apnea Severity? - [Wayne A. Bardwell, Ph.D., Polly Moore, Ph.D., Sonia Ancoli-Israel, Ph.D. and Joel E. Dimsdale, M.D.]

A polysomnographic and clinical report on sleep-related injury in 100 adult patients - [Steve Joncas, BSc, Antonio Zadra, PhD, Jean Paquet, PhD and Jacques Montplaisir, MD PhD, CRCPc]

The value of sleep deprivation as a diagnostic tool in adult sleepwalkers - [Roger J. Broughton]

Sleepwalking Violence: A Sleep Disorder, a Legal Dilemma, and a Psychological Challenge - [Rosalind Cartwright, Ph.D.]

Insomnia in Young Men and Subsequent Depression - [Patricia P. Chang1,, Daniel E. Ford1,2,3, Lucy A. Mead1, Lisa Cooper-Patrick1,2 and Michael J. Klag]

Sleep Disturbance and Risk for Alcohol-Related Problems - [Rosa M. Crum, M.D., M.H.S., Carla L. Storr, Sc.D., Ya-Fen Chan, M.S.N. and Daniel E. Ford, M.D., M.P.H.]

Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex - [Joseph Wu, M.D., Monte S. Buchsbaum, M.D., J. Christian Gillin, M.D., Cheuk Tang, M.S., Stephanie Cadwell, B.A., Michael Wiegand, M.D., Ahmad Najafi, Ph.D., Eric Klein, B.S., Kaye Hazen, B.S. and William E. Bunney, Jr., M.D.]

Neurobiology of Non-REM Sleep in Depression: Further Evidence for Hypofrontality and Thalamic Dysregulation - [Anne Germain, Ph.D., Eric A. Nofzinger, M.D., David J. Kupfer, M.D. and Daniel J. Buysse, M.D.]

REM Sleep and the Early Development of Posttraumatic Stress Disorder - [Thomas A. Mellman, M.D., Victoria Bustamante, Psy.D., Ana I. Fins, Ph.D., Wilfred R. Pigeon, Ph.D. and Bruce Nolan, M.D.]

Sleep Complaints and Depression in an Aging Cohort: A Prospective Perspective - [Robert E. Roberts, Ph.D., Sarah J. Shema, M.S., George A. Kaplan, Ph.D. and William J. Strawbridge, Ph.D.]

Sleep-Related Functioning in Euthymic Patients With Bipolar Disorder, Patients With Insomnia, and Subjects Without Sleep Problems - [Allison G. Harvey, Ph.D., D. Anne Schmidt, B.A., Antonina Scarnà, Ph.D., Christina Neitzert Semler, D.Phil. And Guy M. Goodwin, F.R.C.Psych.]

Cognitive Behavior Therapy and Paroxetine in the Treatment of Hypochondriasis: A Randomized Controlled Trial - [Anja Greeven, M.Sc., Anton J.L.M. van Balkom, M.D., Ph.D., Sako Visser, Ph.D., Jille W. Merkelbach, M.D., Yanda R. van Rood, Ph.D., Richard van Dyck, M.D., Ph.D., A.J. Willem Van der Does, Ph.D., Frans G. Zitman, M.D., Ph.D. and Philip Spinhoven, Ph.D.]

Treatment of Acute Posttraumatic Stress Disorder With Brief Cognitive Behavioral Therapy: A Randomized Controlled Trial - [Marit Sijbrandij, M.A., Miranda Olff, Ph.D., Johannes B. Reitsma, M.D., Ph.D., Ingrid V.E. Carlier, Ph.D., Mirjam H. de Vries, M.A. and Berthold P.R. Gersons, M.D., Ph.D.]

A Randomized, Controlled Trial With 6-Month Follow-Up of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Severe Depression - [Savitha Eranti, M.D., M.R.C.Psych., Andrew Mogg, M.R.C.Psych., Graham Pluck, Ph.D., Sabine Landau, Ph.D., Rick Purvis, B.Sc., Richard G. Brown, Ph.D., Robert Howard, M.D., M.R.C.Psych., Martin Knapp, Ph.D., Michael Philpot, F.R.C.Psych., Sophia Rabe-Heske]

Psychiatric Disorders Among Survivors of the Oklahoma City Bombing - [Carol S. North, MD, MPE; Sara Jo Nixon, PhD; Sheryll Shariat, MPH; Sue Mallonee, RN, MPH; J. Curtis McMillen, PhD; Edward L. Spitznagel, PhD; Elizabeth M. Smith, PhD]

Psychosocial Intervention for Postdisaster Trauma Symptoms in Elementary School Children - [Claude M. Chemtob, PhD; Joanne P. Nakashima, Med; Roger S. Hamada, PhD]

Risk-Taking Behaviors Among Israeli Adolescents Exposed to Recurrent Terrorism: Provoking Danger Under Continuous Threat? - [Ruth Pat-Horenczyk, Ph.D., Osnat Peled, M.A., Tomer Miron, M.A., Daniel Brom, Ph.D., Yael Villa, Ph.D. and Claude M. Chemtob, Ph.D.]

Independent Domains of Inhibitory Gating in Schizophrenia and the Effect of Stimulus Interval - [L. Elliot Hong, M.D., Ann Summerfelt, M.A., Ikwunga Wonodi, M.D., Helene Adami, M.S.W., Robert W. Buchanan, M.D. and Gunvant K. Thaker, M.D.]

Service Costs of Caring for Adolescents With Mental Illness in a Rural Community, 1993–2000 - [E. Jane Costello, Ph.D., William Copeland, Ph.D., Alexander Cowell, Ph.D. and Gordon Keeler, M.S.]

A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression - [Mark A. Frye, M.D., Heinz Grunze, M.D., Trisha Suppes, M.D., Ph.D., Susan L. McElroy, M.D., Paul E. Keck Jr., M.D., Jorge Walden, M.D., Gabriele S. Leverich, M.S.W., L.C.S.W.-C., Lori L. Altshuler, M.D., Shoshanna Nakelsky, M.P.H., Sun Hwang, M.S., Jim Mi]

Parental Diagnoses in Youth With Narrow Phenotype Bipolar Disorder or Severe Mood Dysregulation - [Melissa A. Brotman, Ph.D., Layla Kassem, Ph.D., Michelle M. Reising, B.A., Amanda E. Guyer, Ph.D., Daniel P. Dickstein, M.D., Brendan A. Rich, Ph.D., Kenneth E. Towbin, M.D., Daniel S. Pine, M.D., Francis J. McMahon, M.D. and Ellen Leibenluft, M.D.]

Pharmacogenetics of Antidepressant Medication Intolerance - [Greer M. Murphy, Jr., M.D., Ph.D., Charlotte Kremer, M.D., Heidi E. Rodrigues, B.A. and Alan F. Schatzberg, M.D.]

Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report - [Patrick J. McGrath, M.D., Jonathan W. Stewart, M.D., Maurizio Fava, M.D., Madhukar H. Trivedi, M.D., Stephen R. Wisniewski, Ph.D., Andrew A. Nierenberg, M.D., Michael E. Thase, M.D., Lori Davis, M.D., Melanie M. Biggs, Ph.D., Kathy Shores-Wilson, Ph.D., J]

Mirtazapine for PTSD Nightmares - [JONATHAN D. LEWIS, M.D.]

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report - [Maurizio Fava, M.D., A. John Rush, M.D., Stephen R. Wisniewski, Ph.D., Andrew A. Nierenberg, M.D., Jonathan E. Alpert, M.D., Ph.D., Patrick J. McGrath, M.D., Michael E. Thase, M.D., Diane Warden, Ph.D., M.B.A., Melanie Biggs, Ph.D., James F. Luther, M.A.,]

Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort - [Silvia Paddock, Ph.D., Gonzalo Laje, M.D., Dennis Charney, M.D., A. John Rush, M.D., Alexander F. Wilson, Ph.D., Alexa J.M. Sorant, M.A., Robert Lipsky, Ph.D., Stephen R. Wisniewski, Ph.D., Husseini Manji, M.D. and Francis J. McMahon, M.D.]

Antenatal Depression: Navigating the Treatment Dilemmas - [Marlene P. Freeman, M.D.]

Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms - [Chanudda Nabkasorn1,2, Nobuyuki Miyai1, Anek Sootmongkol3, Suwanna Junprasert2, Hiroichi Yamamoto1, Mikio Arita4 and Kazuhisa Miyashita1]

Double-Blind Comparison of Addition of a Second Mood Stabilizer Versus an Antidepressant to an Initial Mood Stabilizer for Treatment of Patients With Bipolar Depression - [L. Trevor Young, M.D., Ph.D., Russell T. Joffe, M.D., Janine C. Robb, B.Sc.N., Glenda M. MacQueen, M.D., Ph.D., Michael Marriott, Ph.D. and Irene Patelis-Siotis, M.D.]

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline - [R. M. POST, L. L. ALTSHULER, G. S. LEVERICH, M. A. FRYE, W. A. NOLEN,R.W. KUPKA, T. SUPPES, S. McELROY, P. E. KECK, K. D. DENICOFF,H. GRUNZE, J.WALDEN, C. M. R. KITCHEN and J. MINTZ]

Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials - [Harm J. Gijsman, Ph.D., M.R.C.Psych., John R. Geddes, M.D., F.R.C.Psych., Jennifer M. Rendell, M.A., Willem A. Nolen, Ph.D. and Guy M. Goodwin, D.Phil., F.R.C.Psych.]

Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression - [Gary S. Sachs, M.D., Andrew A. Nierenberg, M.D., Joseph R. Calabrese, M.D., Lauren B. Marangell, M.D., Stephen R. Wisniewski, Ph.D., Laszlo Gyulai, M.D., Edward S. Friedman, M.D., Charles L. Bowden, M.D., Mark D. Fossey, M.D., Michael J. Ostacher, M.D., M]

Modafinil Add-On in the Treatment of Bipolar Depression - [R. H. Belmaker, M.D.]

Mood-Incongruent Psychotic Features in Bipolar Disorder: Familial Aggregation and Suggestive Linkage to 2p11-q14 and 13q21-33 - [Fernando S. Goes, M.D., Peter P. Zandi, Ph.D., Kuangyi Miao, M.S., Francis J. McMahon, M.D., Jo Steele, B.Eng., Virginia L. Willour, Ph.D., Dean F. MacKinnon, M.D., Francis M. Mondimore, M.D., Barbara Schweizer, R.N., B.S., John I. Nurnberger Jr., , M.D.,]

Successful Tobacco Dependence Treatment in Schizophrenia - [Jill M. Williams, M.D. and Jonathan Foulds, Ph.D.]

Alcohol Use and Anxiety: Diagnostic and Management Issues - [Kathleen T. Brady, M.D., Ph.D., Bryan K. Tolliver, M.D., Ph.D. and Marcia L. Verduin, M.D.]

儿童期双相障碍的界定 - [S. Nassir Ghaemi, M.D., M.P.H.Bipolar Disorder Research Program Emory University School of Medicine Atlanta, Ga. And Andrés Martin, M.D., M.P.H.]

Early Psychosocial Intervention Following Traumatic Events - [Jonathan I. Bisson, D.M., F.R.C.Psych., Mark Brayne, M.A., Frank M. Ochberg, M.D. and George S. Everly Jr., Ph.D.]

Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison - [Joseph P. McEvoy, M.D., Jeffrey A. Lieberman, M.D., Diana O. Perkins, M.D., M.P.H., Robert M. Hamer, Ph.D., Hongbin Gu, Ph.D., Arthur Lazarus, M.D., M.B.A., Dennis Sweitzer, Ph.D., Christina Olexy, Peter Weiden, M.D. and Stephen D. Strakowski, M.D.]

Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets - [Robert D. Gibbons, Ph.D., C. Hendricks Brown, Ph.D., Kwan Hur, Ph.D., Sue M. Marcus, Ph.D., Dulal K. Bhaumik, Ph.D. and J. John Mann, M.D.]

Connections in Schizophrenia - [Kelvin O. Lim, M.D.]

Cognition, Drug Treatment, and Functional Outcome in Schizophrenia: A Tale of Two Transitions - [Michael F. Green, Ph.D.]

Antidepressants and Suicidal Behavior: Cause or Cure? - [David Brent, M.D.]

Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy - [Gregory E. Simon, M.D., M.P.H. and James Savarino, Ph.D.]

Psychotherapy for bulimia nervosa and binging - [PJ Hay, J Bacaltchuk, S Stefano]

Family therapy for depression - [HT Henken, MJH Huibers, R Churchill, K Restifo, J Roelofs]

A Preliminary Study of Dopamine Transporter Binding in Bipolar and Unipolar Depressed Patients and Healthy Controls - [Jay D. Amsterdama, Andrew B. Newbergb]

Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care - [Thomas A. Mellman, M.D., Notalelomwan Aigbogun, M.S., Ruth Elaine Graves, Ph.D., William B. Lawson, M.D., Ph.D., Tanya N. Alim, M.D.]

Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Demographic and Clinical Characteristics - [Frazier, Jean A.M.D.; McClellan, Jon M.D.; Findling, Robert L.M.D.; Vitiello, Benedetto M.D.; Anderson, Robert B.S.; Zablotsky, Benjamin B.A.; Williams, Emily M.Ed.; McNamara, Nora K.M.D.; Jackson, Joseph A.D.O.; Ritz, Louise M.B.A.; Hlastala, Stefanie A.]

Facial Emotion Processing in Acutely Ill and Euthymic Patients With Pediatric Bipolar Disorder - [Schenkel, Lindsay S.Ph.D.; Pavuluri, Mani N.M.D., Ph.D.; Herbener, Ellen S.Ph.D.; Harral, Erin M.B.A.; Sweeney, John A.Ph.D]

Association between BanI genotype and increased phospholipase A2 activity in schizophrenia - [Nadia R. Barbosa1, Ricardo M. Junqueira1, Homero P. Vallada1 and Wagner F. Gattaz1]

The influence of symptoms of prolonged grief disorder, depression, and anxiety on quality of life among bereaved adults : A prospective study - [Paul A. Boelen1 and Holly G. Prigerson2]

Neuropsychological performance in partly remitted unipolar depressive patients: focus on executive functioning - [Jens Westheide1, Michael Wagner1, Boris B. Quednow2, Christian Hoppe3, Déirdre]

Recognition and Management of Depression in a Substance Use Disorder Treatment Population - [G. M. Curran 1,2; B. M. Booth 1,2; J. E. Kirchner 1,2; D. E. Deneke 2]

Passiflora for anxiety disorder - [LS Miyasaka, AN Atallah, BGO Soares]

Psychostimulants for depression - [B Candy, L Jones, R William, A Tookman, M King]

初级保健机构中双相障碍患者的诊断情况 - [Ruth Elaine Gravesa, Tanya N Alima, Notalelomwan Aigboguna, Kris Chrishonb, Thomas A Mellmana, Dennis S Charneyc, William B Lawsona]

A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders - [Susan L McElroya, Mark A Fryeb, Lori L Altshulerb, Trisha Suppesc, Gerhard Hellemannd, David Blacke, Jim Mintzd, Ralph Kupkaf, Willem Noleng, Gabriele S Leverichh, Kirk D Denicoffh, Robert M Posti, Paul E Keck Jra,j]

Measuring anxiety and depression in the oncology setting using visual-digital scales - [Erik Onel?v 1; Gunnar Steineck 1,2; Ullakarin Nyberg 1,3; Arna Hauksdóttir 1; Ulrika Kreicbergs 4,5; Lars Henningsohn 1,6; Karin Bergmark 1,7; Unnur Valdimarsdóttir 1,8]

Schizophrenia and Pathological Gambling - [Laurence Borras ; Philippe Huguelet]

Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods - [McClellan, Jon M.D.; Sikich, Linmarie M.D.; Findling, Robert L.M.D.; Frazier, Jean A.M.D.; Vitiello, Benedetto M.D.; Hlastala, Stefanie A.Ph.D.; Williams, Emily M.Ed.; Ambler, Denisse M.D.; Hunt-Harrison, Tyehimba M.D.; Maloney, Ann E.M.D.; Ritz, Louise M]

Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment - [Subramaniam, Geetha A.M.D.; Stitzer, Maxine A.Ph.D.; Clemmey, Philip Ph.D.; Kolodner, Ken Sc.D.; Fishman, Marc J.M.D]

Complicated grief after traumatic loss : A 14-month follow up study - [Anette Kersting1, K. Kroker1, J. Steinhard2, K. Lüdorff1, U. Wesselmann1, P. Ohrmann1, V. Arolt1 and T. Suslow1]

Depressive Symptoms and All-Cause Mortality After Heart Transplantation - [Havik, Odd E.1,4; Sivertsen, Borge1; Relbo, Anne2; Hellesvik, Marit2; Grov, Ingelin2; Geiran, Odd3; Andreassen, Arne K.2; Simonsen, Svein2; Gullestad, Lars2]

2007年国际神经精神学会议介绍 - [.]

酒精解毒作用和社交焦虑症：米氮平给药影响的初步研究 - [Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G]

米氮平加用西酞普兰致不伴有抑郁症状强迫症病人治疗反应加速的初步研究 - [Pallanti S, Quercioli L, Bruscoli M]

米氮平治疗强迫症：双盲中止后开放性实验 - [Koran LM, Gamel NN, Choung HW, et al]

交互式电讯记录不同剂量给药方案下米氮平对病人警觉和睡眠的影响 - [Radhakishun FS, van den Bos J, van der Heijden BC, et al]

米氮平对于抑郁症病人睡眠连续性和结构急性效应的初步研究 - [Winokur A, Sateia MJ, Hayes JB, et al]

米氮平对于睡眠影响的由青年健康志愿者参加的安慰剂对照双盲研究 - [Aslan S, Isik E, Cosar B]

睡眠生理测定条件下米氮平和氟西汀对重性抑郁伴有失眠病人的效应比较 - [Winokur A, DeMartinis NA 3rd, McNally DP, et al]

米氮平比SSRIs起效更快吗? - [Quitkin FM,Taylor BP, Kremer C.]

快速起效抗抑郁药治疗策略的药理学 - [Blier P]

抗抑郁药的早发疗效：不同分析的结果 - [Thompson C]

米氮平和帕罗西汀对重性抑郁患者的早期改善可高灵敏度预测后期稳定有效与缓解 - [Szegedi A, Muller MJ, Anghelescu I, et al]